Myrtecaine

Myrtecaine
Clinical data
Trade names	Algesal, Algésal Suractivé
Other names	Nopoxamine
ATC code	none;
Identifiers
	IUPAC name 2-[2-(6,6-Dimethyl-2-bicyclo[3.1.1]hept-2-enyl)ethoxy]-N,N-diethylethanamine;
JSmol)	Interactive image;
	SMILES CCN(CC)CCOCCC1=CCC2CC1C2(C)C;
	InChI InChI=1S/C17H31NO/c1-5-18(6-2)10-12-19-11-9-14-7-8-15-13-16(14)17(15,3)4/h7,15-16H,5-6,8-13H2,1-4H3; Key:BZRYYBWNOUALTQ-UHFFFAOYSA-N;

Myrtecaine (Nopoxamine), sold as a combination product with

tendinitis or ligament sprains and joint pain.^[2]^[3]^[4] It is a surface anaesthetic, adds to the analgesic and anti-inflammatory actions of diethylamine salicylate by facilitating its penetration.^[5] Also myrtecaine has a muscle relaxant effect.^[2]

References

^ "Myrtecaine". PubChem. National Center for Biotechnology Information, U.S. National Library of Medicine. Retrieved 2020-08-22.
^ ^a ^b ^c "Algesal-Creme" (in German). Bundesamt für Sicherheit im Gesundheitswesen. December 2017.
^ ^a ^b "Myrtecaine". Drugster.org.
ISBN 978-1-4757-2085-3
.

^ "Algesal Cream - Patient Information Leaflet" (PDF). Chemipharm Pharmaceutical Industries, Inc.

drug article is a stub. You can help Wikipedia by expanding it.
v
t
e

[1] "Myrtecaine". PubChem. National Center for Biotechnology Information, U.S. National Library of Medicine. Retrieved 2020-08-22.

[AC-2] "Algesal-Creme" (in German). Bundesamt für Sicherheit im Gesundheitswesen. December 2017.

[Drugster-3] "Myrtecaine". Drugster.org.

[4] ISBN 978-1-4757-2085-3
.

[5] "Algesal Cream - Patient Information Leaflet" (PDF). Chemipharm Pharmaceutical Industries, Inc.

[1]

[2]

[3]

[4]

[5]